Published in Am J Med on June 01, 1970
Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest (1975) 2.44
Interferon, antibody, and other host factors in herpes zoster. J Clin Invest (1972) 1.64
Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest (1976) 1.59
Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41
Mixed-lymphocyte reaction as a measure of immunological competence of lymphocytes from patients with Crohn's disease. Gut (1974) 1.34
Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest (1980) 1.19
Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes. Clin Exp Immunol (1975) 1.17
Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes. J Clin Invest (1973) 1.11
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood (2013) 1.02
B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy. Clin Exp Immunol (1976) 0.97
Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases. Clin Exp Immunol (1975) 0.94
Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole. Clin Exp Immunol (1977) 0.92
'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease. Clin Exp Immunol (1973) 0.89
Quantitation of immunocompetence in Hodgkin's disease. J Clin Invest (1975) 0.88
'Antigenic' disparity between leukaemic lymphoblasts and normal lymphocytes in identical twins. Clin Exp Immunol (1972) 0.87
Cell-mediated immunity and its role in resistance to infection. West J Med (1977) 0.85
[Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)]. Arch Otorhinolaryngol (1981) 0.81
Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease. Clin Exp Immunol (1974) 0.79
Immune function of successfully treated lymphoma patients. J Clin Invest (1976) 0.77
Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity. Clin Exp Immunol (1978) 0.76
Concanavalin A receptors on the surface membrane of lymphocytes from patient's with Hodgkin's disease and other malignant lymphomas. Proc Natl Acad Sci U S A (1975) 0.75
Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood (1984) 3.65
Editorial: Measurement of delayed skin-test responses. N Engl J Med (1975) 2.99
Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes. J Lab Clin Med (1973) 1.75
An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer (1987) 1.72
Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer (2006) 1.71
A unique 'leukaemic' T lymphoid cell line: absence of stimulating effect in mixed lymphocyte reaction. Lack of MLR-S in leukaemic T lymphoid cells. Clin Exp Immunol (1973) 1.59
[Correlation between gene expression of CCK-A receptor and gallbladder emptying in gallstone patients]. Zhonghua Wai Ke Za Zhi (1999) 1.56
Simplified whole blood method for evaluating in vitro lymphocyte reactivity of laboratory animals. Clin Exp Immunol (1972) 1.54
Curculigo orchioides, a traditional Chinese medicinal plant, prevents bone loss in ovariectomized rats. Maturitas (2008) 1.46
A bone regenerative approach to alveolar ridge maintenance following tooth extraction. Report of 10 cases. J Periodontol (1997) 1.39
Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin. Cancer (1972) 1.37
Antagonism between the effects of insulin and glucagon on the isolated liver. Diabetes (1969) 1.34
Effect of platelet transfusion on hemorrhage in patients with acute leukemia. An autopsy study. Cancer (1966) 1.28
A post-reconstruction method to correct cupping artifacts in cone beam breast computed tomography. Med Phys (2007) 1.27
Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood (1990) 1.22
In vitro lymphocyte response to autologous cultured lymphoid cells. Proc Soc Exp Biol Med (1971) 1.20
Enhancement of in vitro lymphocyte response by neuraminidase. Clin Exp Immunol (1973) 1.16
Complications of BCG vaccination in neoplastic disease. Ann Intern Med (1975) 1.16
Postoperative immunosuppression in patients with breast cancer. Lancet (1972) 1.15
Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines. Cancer Res (1972) 1.15
The use of a porous hydroxylapatite implant in periodontal defects. I. Clinical results after six months. J Periodontol (1985) 1.14
A simplified technique for in vitro studies of lymphocyte reactivity. Proc Soc Exp Biol Med (1972) 1.12
"Antigenic" disparity between cultured lymphoid cells and autologous lymphocytes. Am J Med (1972) 1.11
Blastogenic response of normal lymphocytes to cultured lymphoid cells and non-lymphoid neoplastic cells. Immunology (1972) 1.11
Immunotherapy in well-controlled chronic myelocytic leukemia. N Y State J Med (1973) 1.10
Immunoregulatory T cell function in multiple myeloma. J Clin Invest (1981) 1.10
In vitro functional studies of mononuclear cells in patients with CLL: evidence for functionally normal T lymphocytes and monocytes and abnormal B lymphocytes. Cancer (1979) 1.09
Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines. J Natl Cancer Inst (1975) 1.07
Human chorionic gonadotropin. Its inhibitory effect on cell-mediated immunity in vivo and in vitro. Immunology (1975) 1.07
Bone formation within porous hydroxylapatite implants in human periodontal defects. J Periodontol (1986) 1.06
Marker profiles of human leukemia and lymphoma cell lines. J Cancer Res Clin Oncol (1981) 1.06
Salmonellosis in disseminated malignant diseases. A seven-- year review (1959-1965). N Engl J Med (1967) 1.05
Day 3 morphology is a poor predictor of blastocyst quality in extended culture. Fertil Steril (2000) 1.05
Glucagon--an essential hormone. Am J Med (1966) 1.05
Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells. J Natl Cancer Inst (1974) 1.04
Inhibitory effect of human chorionic gonadotrophin on lymphocyte blastogenic response to mitogen, antigen and allogeneic cells. Clin Exp Immunol (1974) 1.02
Philadelphia-chromosome-positive and -negative chronic myelocytic leukemia. Ann Intern Med (1970) 1.01
Effect of glucagon on gluconeogenesis by the isolated perfused rat liver. Endocrinology (1966) 1.01
Human thymus cells. Excellent responders but poor stimulators in 'One Way' mixed lymphocyte reaction. Immunology (1976) 0.99
Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia. Cancer (1973) 0.98
Delay in progression of malignant lymphoma after BCG vaccination. N Engl J Med (1974) 0.97
Benign monoclonal B cell lymphocytosis--a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood (1984) 0.97
Second neoplasms with chronic lymphocytic leukemia. N Y State J Med (1976) 0.97
Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosis. J Cell Physiol (1996) 0.97
L-asparaginase and in vitro lymphocyte blastogenesis. Cell membrane alteration as possible mechanism of inhibitory effect. Immunology (1974) 0.96
Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data. J Clin Oncol (1984) 0.95
Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2. J Neurosci Res (2005) 0.95
Immunotherapy of prostatic carcinoma with bacillus Calmette-Guerin. Cancer Chemother Rep (1975) 0.94
Glycol methacrylate (GMA) embedding for light microscopy. II. Immunohistochemical analysis of semithin sections of undecalcified marrow cores. J Clin Pathol (1988) 0.94
Pyrogen in the urine of febrile patients with Hodgkin's disease. Nature (1967) 0.93
Stimulating capacity of fresh and cultured human leukaemic lymphoid and myeloid cells in 'one-way' mixed lymphocyte reaction. Immunology (1977) 0.93
T and B lymphocytes. Exclusive role as responders and stimulators in human one-way mixed lymphocyte reaction. Immunology (1976) 0.93
Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count. N Y State J Med (1973) 0.93
Cystic lesion of the ventriculus terminalis in an adult. J Clin Neurosci (2010) 0.93
Depression of T lymphocyte response by non-T suppressor cells in lung cancer patients: a possible prognostic value of suppressor-cell activity. Cancer (1979) 0.91
Effect of BCG on delayed hypersensitivity responses of patients with neoplastic disease. Int J Cancer (1973) 0.91
Correlation of surface markers of cells of human lymphatic leukemias with disease type. J Natl Cancer Inst (1977) 0.91
In vitro preferential effect of irradiation on cultured T lymphoid cell line. Clin Exp Immunol (1974) 0.90
Immunologic and biologic properties of antibodies to a glucagon-serum albumin polymer. Endocrinology (1970) 0.90
Basal plasma glucagon levels of man. J Clin Invest (1967) 0.90
Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy. Gene Ther (2004) 0.90
Cellular immune responses and prognosis in malignant lymphomas. Natl Cancer Inst Monogr (1971) 0.89
Cloning of the t(11;14)(q13;q32) translocation breakpoints from two human leukemia cell lines. Leukemia (1991) 0.89
'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease. Clin Exp Immunol (1973) 0.89
Response to BCG vaccination and survival in advanced Hodgkin's disease. Cancer (1969) 0.89
Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood (1985) 0.89
Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice. J Aerosol Med Pulm Drug Deliv (2013) 0.88
Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model. Gene Ther (2006) 0.88
B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro. Blood (1986) 0.88
Studies of correlation of lymphocyte response to phytohemagglutinin with the clinical and immunologic status in chronic lymphocytic leukemia. Cancer (1973) 0.88
Myeloid leukemia in Hodgkin's disease: chromosomal abnormalities. Ann Intern Med (1969) 0.87
Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer (2000) 0.87
Enhancement of delayed skin hypersensitivity by neuraminidase in cancer patients. Clin Exp Immunol (1974) 0.87
'Antigenic' disparity between leukaemic lymphoblasts and normal lymphocytes in identical twins. Clin Exp Immunol (1972) 0.87
Cross-sectional and dynamic change of serum metabolite profiling for Hepatitis B-related acute-on-chronic liver failure by UPLC/MS. J Viral Hepat (2013) 0.87
Chronic lymphocytic leukemia in Hodgkin's disease. Report of a case and review of the literature. Cancer (1971) 0.86
Mode of spread in patients with localized malignant lymphoma. Arch Intern Med (1967) 0.86
Use of a robotic sampling platform to assess young children's exposure to indoor bioaerosols. Indoor Air (2011) 0.86
Preimplantation genetic diagnosis and screening. Semin Reprod Med (2005) 0.86
Defective immunoregulatory T-cell function in chronic lymphocytic leukemia. Blood (1981) 0.86
Human leukemia-associated antigens: detection on cells of established lymphoblastoid lines. J Immunol (1975) 0.86
T-lymphocyte dependency of B-lymphocyte blastogenic response to phytomitogens. Immunology (1978) 0.85
Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. N Engl J Med (1984) 0.85
Effect of glucagon on phosphorylase activity of the isolated perfused liver. Am J Physiol (1969) 0.85
Clinical significance of monoclonal proteins in chronic lymphocytic leukemia. Leukemia (1992) 0.85
Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients. Cancer (1980) 0.85
T-cell chronic lymphocytic leukemia: report of a case and review of the literature. Cancer (1979) 0.85
Comparison of glucagon and epinephrine effects in the dog. Endocrinology (1966) 0.85
The influence of histologic type on survival in non-Hodgkin's lymphoma. Cancer (1981) 0.85
Proceedings: Transfer of cell-mediated skin reactivity with "immune" RNA in Hodgkin's disease and other neoplastic diseases. Cancer (1974) 0.85